Apatinib can inhibit the expression of hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor and phosphoinositide 3-kinase (PI3K)/Akt/mTOR signalling pathway markers and promote apoptosis in PC cells [6, 7]. Here, HIF1A is linked to pachyonychia congenita.